Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Rituximab in Treating Patients With Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating rituximab in Hodgkin lymphoma has completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs [Phase 2]
A Phase 2 safety and tolerability trial evaluating CDX-301 with or without plerixafor for stem cell mobilization in matched related donor/re…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [Phase 2]
Phase 2 clinical trial evaluating nonmyeloablative allogeneic stem cell transplantation for various hematologic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating brentuximab vedotin in combination with bendamustine in Hodgkin lymphoma have been posted after th…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
This clinical trial update summarizes the risk of fatigue in adolescent and young adult Hodgkin lymphoma patients from the completed NCT0122…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [NA]
A terminated clinical trial evaluated mobilizing donor peripheral blood stem cells with plerixafor and filgrastim before donor transplant in…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years [Phase 2]
A Phase II clinical trial evaluating VEPEMB in patients with Hodgkin lymphoma aged 60 years and older has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
A Phase 1 trial investigates a three-drug combination (bendamustine, clofarabine, and etoposide) in younger patients with relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment [NA]
Clinical trial results posted on using hyperbaric oxygen therapy to improve umbilical cord blood stem cell homing and engraftment in patient…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase II trial results assess the combination of panobinostat and lenalidomide in patients with relapsed or refractory Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hema…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Tandem Auto-Allo Transplant for Lymphoma [Phase 2]
Phase 2 clinical trial update on tandem auto-allo transplantation for various lymphomas, with completed status and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia [NA]
A pediatric oncology trial evaluated yoga to alleviate fatigue, anxiety, and pain in adolescents undergoing treatment for leukemia or lympho…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease [Phase 3]
Phase 3 clinical trial evaluating whether adding additional chemotherapy and/or radiation therapy to standard chemotherapy improves outcomes…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease [Phase 3]
This completed Phase 3 trial evaluated radiotherapy with or without the chemotherapy combination of doxorubicin and vinblastine in early-sta…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant [Phase 2]
Phase 2 trial of T-cell replete haploidentical donor hematopoietic stem cell transplantation with natural killer (NK) cell support in hemato…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of ANGEL, an EBV-specific cytotoxic T-cell therapy for relapsed Epstein…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [Phase 1, Phase 2]
Phase 1 and Phase 2 results are reported for allogeneic cytokine-induced killer (CIK) cell immunotherapy given to patients who relapsed afte…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma [Phase 3]
Phase 3 trial of combination chemotherapy followed by radiation therapy in children with newly diagnosed Hodgkin lymphoma; results posted af…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allogeneic Transplantation From Related Haploidentical Donors [Phase 2]
A Phase 2 clinical trial evaluating allogeneic transplantation from related haploidentical donors for blood cancers and leukemia has complet…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating bendamustine hydrochloride for relapsed and primary refractory Hodgkin lymphoma has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of LBH589 (panobinostat) in patients with recurrent or refractory Hodgkin lymphoma or non-Hodgkin lymphoma has been terminated…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Low Dose Chest Computed Tomography (CT) Screening
This update reports a completed clinical trial evaluating low-dose chest CT screening in patients with Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma [Phase 1]
An early-phase (Phase I/II) study of Abraxane in recurrent and refractory lymphoma was terminated. The trial involved non-Hodgkin lymphoma a…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT) [Phase 1]
Phase 1 trial update of immunostimulatory CpG SD-101 plus radiation therapy for recurrent/progressive lymphoma after allogeneic hematopoieti…